Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells

Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells

US Patent 7101543 · Granted Sep 5, 2006

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utiliz2012
Genetically modified cells expressing a TGF beta inhibitor, the cells being lung2010
Compositions and methods for enhanced tumor cell immunity in vivo2002
Compositions and methods for enhanced tumor cell immunity in vivo2000
Compositions and methods for enhanced tumor cell immunity in vivo1998
Lymphokine gene therapy of cancer1997